IL6 and rheumatoid arthritis: In human RA pathology, the effect of VIP as anti-inflammatory peptide was confirmed in synovial tissue cells and FLS from RA patients, where VIP downregulated chemokine production and IL-6 more clearly after stimulation with TNFα [102].